We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMQQ icon
10676
FMQQ The Next Frontier Internet & Ecommerce ETF
FMQQ
$21.5M
$186K ﹤0.01%
+17,776
New +$220K
GSBD icon
10677
PUT
Goldman Sachs BDC
GSBD
$1.11B
$186K ﹤0.01%
+11,100
New +$205K
IBIO icon
10678
iBio
IBIO
$71M
$186K ﹤0.01%
1,409
+996
+241% +$150K
KAVL
10679
DELISTED
Kaival Brands Innovations Group
KAVL
$186K ﹤0.01%
+5,610
New +$153K
MRAM icon
10680
CALL
Everspin Technologies
MRAM
$460M
$186K ﹤0.01%
35,400
-49,000
-58% -$315K
PARR icon
10681
PUT
Par Pacific Holdings
PARR
$4.02B
$186K ﹤0.01%
+11,900
New +$187K
PLYA
10682
PUT
DELISTED
Playa Hotels & Resorts
PLYA
$186K ﹤0.01%
27,100
+4,300
+19% +$35.7K
PRCH icon
10683
CALL
Porch Group
PRCH
$1.97B
$186K ﹤0.01%
72,700
+9,400
+15% +$38.9K
SENS icon
10684
PUT
Senseonics Holdings Inc
SENS
$413M
$186K ﹤0.01%
9,025
-15,215
-63% -$397K
VERV
10685
PUT
DELISTED
Verve Therapeutics
VERV
$186K ﹤0.01%
12,200
-9,900
-45% -$153K
WGS icon
10686
CALL
GeneDx Holdings
WGS
$2.33B
$186K ﹤0.01%
4,467
+794
+22% +$53.9K
ASA
10687
CALL
ASA Gold and Precious Metals
ASA
$1.1B
$185K ﹤0.01%
12,600
-1,100
-8% -$21.2K
MPV
10688
Barings Participation Investors
MPV
$175M
$185K ﹤0.01%
+15,100
New +$193K
NGS icon
10689
CALL
Natural Gas Services Group
NGS
$490M
$185K ﹤0.01%
16,800
-8,600
-34% -$110K
TRC icon
10690
Tejon Ranch
TRC
$442M
$185K ﹤0.01%
+11,904
New +$205K
HGEN
10691
DELISTED
HUMANIGEN, INC.
HGEN
$185K ﹤0.01%
104,795
-89,374
-46% -$201K
BUR icon
10692
CALL
Burford Capital
BUR
$960M
$184K ﹤0.01%
+18,200
New +$160K
DLHC icon
10693
PUT
DLH Holdings
DLHC
$67.5M
$184K ﹤0.01%
12,100
-3,400
-22% -$55.4K
DRRX
10694
CALL
DELISTED
DURECT Corp
DRRX
$184K ﹤0.01%
38,520
+18,130
+89% +$86.6K
LVO icon
10695
LiveOne
LVO
$57.2M
$184K ﹤0.01%
21,513
+10,740
+100% +$88.1K
ASXC
10696
DELISTED
Asensus Surgical, Inc.
ASXC
$184K ﹤0.01%
461,485
-1,232,974
-73% -$550K
SMED
10697
DELISTED
Sharps Compliance Corp
SMED
$184K ﹤0.01%
62,818
-58,631
-48% -$245K
CMCL icon
10698
PUT
Caledonia Mining Corp
CMCL
$434M
$183K ﹤0.01%
+16,700
New +$228K
KRRO icon
10699
Korro Bio
KRRO
$196M
$183K ﹤0.01%
+2,453
New +$166K
PACB icon
10700
PUT
Pacific Biosciences
PACB
$357M
$183K ﹤0.01%
41,500
-500
-1% -$3.04K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.